"I eat, breathe, live biotech,â€ť says Ryan Bethencourt. â€śItâ€™s really all I do at this point.â€ť
Ryan Bethencourt seized his opportunity back in 2008. That made him an outlier: most people, after all, were seizing pink slips, not opportunities. But while the Great Recession wiped out billions in home equity and blew up companies by the score, it also freed up plenty of hard assets. In simple terms, you could buy a lot of expensive stuff for a song. And thatâ€™s just what Bethencourt and his pal, molecular biologist and fellow DIYbio enthusiast, John Schloendorn, did.
â€śThe financial crisis resulted in the liquidation of a big chunk of the biotechnology sector,â€ť says Bethencourt, a molecular geneticist-cum-biotech entrepreneur who was working as a business development director for a clinical research organization at the time. â€śSo we bought up a lot of research-grade equipment. We felt we couldnâ€™t afford to pass it up.â€ť Read more…